|
|
Innocell Corp - Comparative Business Analysis Snapshot
Business Description
Innocell Corp. The Company's principal actvity is developing immune cell treatment drugs and the storage of immune cells. The Company's offerings include immune cell therapy, which is an anti cancer therapy using immune cells from the patient's own body; life cell bank, which collects and freezes anti cancer immune cells before receiving therapy that can weaken the immune system; cord blood bank, which stores hematopoietic stem cells and stem cells that are separated from core blood at an ultra low temperature, and extreme drug resistance (EDR) assay service, which is a test for patient's resistance to anti cancer drugs. The Company is also involved in the distribution of information technology (IT) products.
Competitor Analysis
This analysis compares Innocell Corp with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
